REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Dr. Vaczine Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Dr. Vaczine Szentlelek Gyogyszertar Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Dr. Vaczine Bt. is based in Hungary. The head office is in Gyor. It operates in the Pharmacies and Drug Stores industry. The company was established on January 03, 1997. There are currently 15 (2024) people employed by Dr. Vaczine Bt.. In 2023, the company reported a net sales revenue increase of 11.03%. Its’ total assets recorded a growth of 0.92%. Dr. Vaczine Bt.’s net profit margin decreased by 2.83% in 2023.

Headquarters
Mecs L. u. 2/B.
Gyor; Gyor-Moson-Sopron; Postal Code: 9024

Contact Details: Purchase the Dr. Vaczine Bt. report to view the information.

Website: http://www.patika03.t-online.hu

Basic Information
Total Employees:
Purchase the Dr. Vaczine Bt. report to view the information.
Outstanding Shares:
Purchase the Dr. Vaczine Bt. report to view the information.
Registered Capital:
Purchase the Dr. Vaczine Bt. report to view the information.
Financial Auditors:
Purchase the Dr. Vaczine Bt. report to view the information.
Incorporation Date:
January 03, 1997
Key Executives
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Dr. Vaczine Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.03%▲
Total operating revenue
11.02%▲
Operating profit (EBIT)
-18.25%▼
EBITDA
0.77%▲
Net Profit (Loss) for the Period
-22.64%▼
Total assets
0.92%▲
Total equity
5.02%▲
Operating Profit Margin (ROS)
-2.42%▼
Net Profit Margin
-2.83%▼
Return on Equity (ROE)
-5.74%▼
Quick Ratio
-0.02%▼
Cash Ratio
-0.15%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo